| Patient | Ada Lovelace |
|---|---|
| Date of birth | 1990-12-10 |
| Identifiers | MRN HR-NI031-SYN; SSN (made up) 000-31-6729 |
| Document date | 2026-06-02 |
| Author | Constance Whitley-Adeyemi, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for abnormal bleeding and pelvic pain: history, speculum examination and cervical biopsy, blood count and iron studies, conversion of opium tincture to measured oral morphine, an iron infusion, and a gynecologic oncology referral [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1829 | Measles at 13, with a long recovery and about a year in bed | D (CLM-0002) |
| 1837 | Cholera at 21, followed by lingering asthma and digestive problems | D (CLM-0004) |
| from about 1843 | Chronic ill health from her late twenties, with episodes she called heart or rheumatic attacks, treated with several medicines including laudanum and opium | D (CLM-0005, CLM-0007) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | A poet; died at 36; cause not recorded in the cited source | D (CLM-0001) |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Opium tincture (100 mg/mL opium, equivalent to 10 mg/mL morphine), 0.5 mL by mouth four to six times a day as needed for pain | 0.5 mL four to six times a day as needed | Oral route | 2024-06-03 to 2026-06-02 | completed | S |
| Morphine sulfate oral solution 2 mg/mL, 5 mg (2.5 mL by oral syringe) every 4 hours as needed for pain | 5 mg every 4 hours as needed | Oral route | 2026-06-02 | active | S |
| Naloxone 4 mg nasal spray, one spray in a nostril for suspected opioid overdose; call 911 | one spray as needed for suspected overdose; repeat after 2 to 3 minutes if needed | Nasal route | 2026-06-02 | active | S |
| Senna 8.6 mg tablet, two tablets by mouth at night | two tablets at night | Oral route | 2026-06-02 | active | S |
| Polyethylene glycol 3350, 17 g in water by mouth once or twice a day | once daily, up to twice daily | Oral route | 2026-06-02 | active | S |
| Acetaminophen 500 mg tablet, two tablets by mouth three times a day | 1 g three times a day | Oral route | 2026-06-02 | active | S |
| Ferric carboxymaltose 750 mg intravenous infusion, two doses at the first two visits | 750 mg on two occasions two weeks apart | Intravenous route | 2026-06-02 to 2026-06-17 | completed | S |
Positive for the concerns in the history of present illness. Alert, quick and articulate; anxious about the bleeding; mild low mood; PHQ-9 score 8, no thoughts of death or self-harm; no opioid craving or use beyond what is prescribed. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Independent in self-care; tires on stairs; ECOG performance status 1. [S]
Vital signs recorded on 2026-06-02; see the Vital Signs section. Mental status: Alert, quick and articulate; anxious about the bleeding; mild low mood; PHQ-9 score 8, no thoughts of death or self-harm; no opioid craving or use beyond what is prescribed. The physical examination is limited to the findings relevant to this synthetic episode. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-02 | Body height | 165 | cm | S |
| 2026-06-02 | Body weight | 54 | kg | S |
| 2026-06-02 | Body mass index (BMI) [Ratio] | 19.8 | kg/m2 | S |
| 2026-06-02 | Systolic blood pressure | 108 | mm[Hg] | S |
| 2026-06-02 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-06-02 | Heart rate | 96 | /min | S |
| 2026-06-02 | Respiratory rate | 16 | /min | S |
| 2026-06-02 | Body temperature | 36.8 | Cel | S |
| 2026-06-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-02 | Hemoglobin [Mass/volume] in Blood | 8.4 | g/dL | 12-15.5 g/dL | Low | S |
| 2026-06-02 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 74 | fL | 80-100 fL | Low | S |
| 2026-06-02 | Leukocytes [#/volume] in Blood by Automated count | 7.8 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-06-02 | Platelets [#/volume] in Blood by Automated count | 412 | 10*3/uL | 150-400 10*3/uL | High | S |
| 2026-06-02 | Ferritin [Mass/volume] in Serum or Plasma | 5 | ng/mL | 15-150 ng/mL | Low | S |
| 2026-06-02 | Creatinine [Mass/volume] in Serum or Plasma | 0.68 | mg/dL | 0.57-1 mg/dL | Normal | S |
| 2026-06-02 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | 7-35 U/L | Normal | S |
| 2026-06-02 | Albumin [Mass/volume] in Serum or Plasma | 3.6 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-06-02 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma | 1 | m[IU]/mL | Below 5 is negative | Normal | S |
| 2026-06-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 116 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 2026-06-02 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 7 | {score} | S | ||
| 2026-06-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Bleeding between periods and after intercourse, with heavier periods, a watery blood-stained discharge and a constant pelvic ache, for about five months; average pain 7 of 10 despite her opium tincture; a friable cervical mass found on examination and biopsied; cause not yet established at intake | active | confirmed | N93.8 | S — Synthetic presenting problem anchored to her documented final illness; superseded by the diagnosis at the second visit. |
| Iron deficiency anemia from chronic blood loss: hemoglobin 8.4 g/dL, mean cell volume 74 fL, ferritin 5 ng/mL, with tiredness and breathlessness on stairs | active | confirmed | D50.0 | S — Synthetic modern finding anchored to her documented final illness. |
| Long-term prescribed opioid therapy: opium tincture for recurrent pelvic and abdominal pain for about two years, measured at times with a household spoon, converted at intake to measured oral morphine; no opioid use disorder on a DSM-5 assessment; naloxone supplied | active | confirmed | Z79.891 | S — Synthetic modern history anchored to her documented laudanum and opium; not a claim about her real dosing. |